Heartflow (HTFL) CEO logs small Rule 10b5-1 stock sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Heartflow, Inc. Chief Executive Officer John C.M. Farquhar reported an open-market sale of 22,562 shares of Common Stock at $26.72 per share on April 10, 2026. After this trade, he directly holds 549,163 shares, indicating he retained the vast majority of his position.
The filing notes the sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025, suggesting the transaction was scheduled in advance as part of a systematic trading program rather than a spur-of-the-moment decision.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 22,562 shares ($602,857)
Net Sell
1 txn
Insider
Farquhar John C.M.
Role
Chief Executive Officer
Sold
22,562 shs ($603K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 22,562 | $26.72 | $603K |
Holdings After Transaction:
Common Stock — 549,163 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares sold: 22,562 shares
Sale price: $26.72 per share
Shares held after sale: 549,163 shares
+2 more
5 metrics
Shares sold
22,562 shares
Open-market sale of Common Stock on April 10, 2026
Sale price
$26.72 per share
Price for the 22,562 shares sold
Shares held after sale
549,163 shares
CEO’s direct Common Stock holdings following the transaction
Trading plan adoption date
September 12, 2025
Date CEO adopted Rule 10b5-1 trading plan governing this sale
Transaction date
April 10, 2026
Date of reported open-market sale
Key Terms
Rule 10b5-1 trading plan, open-market sale, Common Stock, Form 4
4 terms
Rule 10b5-1 trading plan regulatory
"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan..."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What insider transaction did Heartflow (HTFL) report in this Form 4?
Heartflow (HTFL) reported that CEO John C.M. Farquhar sold 22,562 shares of Common Stock in an open-market transaction at $26.72 per share. The sale was disclosed in a Form 4 insider trading report filed with regulators.
Was the Heartflow (HTFL) CEO’s stock sale part of a Rule 10b5-1 plan?
Yes. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on September 12, 2025. Such plans pre-schedule trades, indicating this sale was arranged in advance rather than timed opportunistically by the executive.
Does this Heartflow (HTFL) Form 4 show any options or derivative exercises?
No derivative securities are listed in this Form 4 excerpt. The filing summarizes a single non-derivative transaction: an open-market sale of Common Stock, with no associated option exercises or other derivative movements shown in the provided data.